Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 349 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Long-term outcomes Clear all

Conditions: Anesthesia, Neurotoxicity, Child Development
Interventions: Sevoflurane, Remifentanil, Dexmedetomidine; Drug
Lead sponsor: Murdoch Childrens Research Institute; Other
Eligibility: Up to 2 Years
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2026
U.S. locations: 5
States / cities: Boston, Massachusetts • Cleveland, Ohio • Philadelphia, Pennsylvania + 2 more

Conditions: Dementia
Interventions: Educational activities to improve dementia care; Behavioral
Lead sponsor: Ryan M. Carnahan; Other
Eligibility: 65 Years and older
Enrollment: 44,524 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Food Insecurity Among Children, Food Insecurity in Post Partum Women, Care Coordination in Primary Care, Preventive Care / Anticipatory Guidance, Retention in Care
Interventions: Nurturing Care Family Navigator; Behavioral
Lead sponsor: University of Nevada, Las Vegas; Other
Eligibility: 18 Years and older · Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Firearm Injury, Violence, Physical
Interventions: Turning the Tide Violence Intervention Program (hospital violence intervention program); Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 16 Years and older
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Smoking, Smoking Cessation
Interventions: Potentially Reduced Exposure Product (PREP): a smokeless, spit-free tobacco product; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 19 Years and older
Enrollment: 1,236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Obesity
Interventions: ACT, SR, WLO; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 30 Years to 65 Years
Enrollment: 190 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Preterm Birth
Interventions: Not listed
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: Up to 1 Year
Enrollment: 239 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Congenital Diaphragmatic Hernia, Congenital Abnormalities, Neonatal Diseases and Abnormalities, Hernia, DIaphragmatic, Congenital, Internal Hernia, Hernia, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Interventions: Fetal Treatment Arm (FETO Group); Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cardiovascular Diseases, Cardiovascular Morbidity, Coronary Heart Disease, Low-density-lipoprotein-type
Interventions: N/A - observational study.; Other
Lead sponsor: University of Sydney; Other
Eligibility: Not listed
Enrollment: 1,137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Autism Spectrum Disorder
Interventions: Intervention JEP; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 36 Months to 54 Months
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: HIV Infection, Sexually Transmitted Infections, Implementation
Interventions: Training Tool for Preventing HIV/AIDS among Teens (PHAT) Life; Behavioral
Lead sponsor: Oregon Research Behavioral Intervention Strategies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Springfield, Oregon

Conditions: Osteoarthritis of the Knee, Traumatic Arthritis of the Knee
Interventions: Total knee arthroplasty; Procedure
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 20 Years to 75 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Musculoskeletal Injury Trauma
Interventions: Integrated care (ICare), Usual Care (UsCare), Patient-Reported Outcomes Measurement Information System, Lower Extremity Gain Scale (LEGS), Dynamometer, Active Range of Motion (AROM), Posttraumatic Stress Disorder (PTSD), Beck Depression Inventory-II, State-Trait Anxiety Inventory (STAI), Tampa Scale of Kinesiophobia-11 (TSK-11); Procedure · Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 85 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Cataract
Interventions: Vivity ACRYSOF IQ IOL Group, ACRYSOF IQ IOL Control Group; Device
Lead sponsor: John Berdahl, MD; Other
Eligibility: Not listed
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Hunter Syndrome
Interventions: Idursulfase-IT, Elaprase; Drug
Lead sponsor: Shire; Industry
Eligibility: Up to 18 Years · Male only
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2024
U.S. locations: 3
States / cities: Oakland, California • Chicago, Illinois • Chapel Hill, North Carolina

Conditions: Bilateral Vestibular Hypofunction, Bilateral Vestibular Deficiency, Bilateral Vestibulopathy, Gentamicin Ototoxicity, Aminoglycoside Toxicity, Vestibular Diseases, Sensation Disorders, Labyrinth Diseases, Other Disorders of Vestibular Function
Interventions: Labyrinth Devices MVI™ Multichannel Vestibular Implant System; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 22 Years to 90 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Non-small Cell Lung Cancer (NSCLC)
Interventions: Nivolumab + ipilimumab, Nivolumab + ipilimumab + platinum-based chemotherapy, Immuno-oncology-based therapy (excluding nivolumab-based regimens) with chemotherapy, Other dual-immuno-oncology therapy with chemotherapy; Biological
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Fleming Island, Florida

Conditions: Atrial Fibrillation
Interventions: Catheter Ablation; Device
Lead sponsor: Heart Rhythm Clinical and Research Solutions, LLC; Other
Eligibility: 18 Years and older
Enrollment: 392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 4
States / cities: Birmingham, Alabama • Annapolis, Maryland • Boston, Massachusetts + 1 more

Conditions: Chronic Low Back Pain, Post-traumatic Stress
Interventions: Pain Neuroscience Education, Exercise, Traditional Education; Behavioral
Lead sponsor: Keller Army Community Hospital; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Endometriosis
Interventions: NettleEndo, Sham NettleEndo Device; Device
Lead sponsor: Samphire Group, Inc.; Industry
Eligibility: 22 Years to 45 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Thalassemia Major
Interventions: Not listed
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 0 Years to 30 Years
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Diabetes Mellitus, Type 2
Interventions: Valsartan 160 mg + nateglinide 60 mg, Valsartan 160 mg + nateglinide placebo, Nateglinide 60 mg + valsartan placebo, Valsartan placebo + nateglinide placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 50 Years to 99 Years
Enrollment: 9,306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2009
U.S. locations: 1
States / cities: Multiple Locations, New Jersey

Conditions: Aortic Aneurysm
Interventions: Endovascular Repair, Standard Open Repair; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years and older
Enrollment: 881 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2012
U.S. locations: 42
States / cities: Birmingham, Alabama • Tucson, Arizona • No. Little Rock, Arkansas + 39 more

Conditions: Hunter Syndrome
Interventions: Idursulfase-IT, Elaprase; Drug
Lead sponsor: Takeda; Industry
Eligibility: 3 Years to 18 Years · Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2024
U.S. locations: 7
States / cities: Chicago, Illinois • Chapel Hill, North Carolina • Portland, Oregon + 4 more

Search by objective public record fields.

A Study to Compare the Long-term Outcomes After Two Different Anaesthetics

Extension Connection Evaluation

Nurturing Care Family Navigator

HVIP Outcomes and Stakeholder Insights

A Test of Short and Long Term Naturalistic Outcomes of Smokers Who Sample Smokeless Tobacco

Using Novel Behavioral Approaches to Improve Long-Term Weight Loss Outcomes

NICU-HEALTH (Hospital Exposures and Long-Term Health)

Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH

Observational Study of Cardiovascular Disease.

Comprehensive Communication Intervention for Minimally Verbal Children With Autism

Technology-based Training Tool for PHAT Life

Long-Term Multicenter Evaluation of the E1® Tibial Bearing

An Integrated-Delivery-of-Care Approach to Improve Patient Outcomes, Safety, Well-Being After Orthopaedic Trauma

Long Term Outcomes of Vivity Intra Ocular Lens(IOL) Versus Control

Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094

Long Term Outcomes After Vestibular Implantation

Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%

Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial Fibrillation (DYNAMIC AF Registry)

Effectiveness of Pain Neuroscience Education (PNE) to Veterans With Post-Traumatic Stress and Low Back Pain

Remote Electrical Stimulation as a Long-term Intervention for Endometriosis Flare Ups

Long Term Outcomes in β Thalassemia Major

Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications

Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (AAA)

An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive Impairment